Is Vanda Pharmaceuticals (VNDA) stock Halal?

Vanda Pharmaceuticals is a biopharmaceutical company primarily focused on the development and commercialization of innovative therapies to address unmet medical needs. The company’s core objective is to discover, develop, and deliver novel treatments for patients suffering from a range of medical disorders, particularly within the areas of central nervous system disorders and other areas of high clinical demand. Before any of that matters to a Muslim investor, one question comes first: is Vanda Pharmaceuticals stock Halal?

Is Vanda Pharmaceuticals Shariah compliant?

No. In the October 2026 screening Vanda Pharmaceuticals (VNDA) does not pass AAOIFI screening: it fails the interest-bearing investments screen. The Shariah case on a technology company like Vanda Pharmaceuticals is rarely about the product. What AAOIFI Shariah Standard No. 21 examines is the money around the product: cash parked in instruments that earn Riba, borrowing measured against a market capitalisation that moves daily, and any incidental income from sources Islam prohibits, which must stay below 5% of revenue.

Does Vanda Pharmaceuticals pass the business activity test?

The activity screen is only part of the picture this month: Vanda Pharmaceuticals currently fails the interest-bearing investments screen, so the overall verdict is not compliant regardless of the business itself. The watch item for technology names is incidental: cash returns and platform content can carry impermissible elements, which AAOIFI tolerates only below the thresholds.

Is Vanda Pharmaceuticals' income Halal?

Yes, within AAOIFI's tolerance. Vanda Pharmaceuticals' income from non-permissible sources stays below 5% of revenue in the October 2026 screening.

Does Vanda Pharmaceuticals meet AAOIFI's debt and investment ratio requirements?

Not in full. Interest bearing investments currently exceed the 30% cap, measured against a market capitalisation of $297M (market data as of 1 October 2026), while the other ratio stays within it. One breach is enough to fail the screening; the ratios are reassessed monthly under our Shariah Supervisory Board.

Why do other halal screeners show a different verdict for Vanda Pharmaceuticals?

Screeners can disagree without either being wrong. AAOIFI Shariah Standard No. 21, which Tabadulat applies, measures interest bearing debt and investments against market capitalisation with a 30% ceiling. MSCI and FTSE measure them against total assets with a 33% ceiling, and S&P and Dow Jones Islamic use a multi year average of market capitalisation. Data dates differ too, because each provider reads filings and prices on its own schedule. The same company can therefore pass one standard and fail another in the same month. Tabadulat publishes one answer, the AAOIFI result as of October 2026, and re-screens it every month.

Tabadulat is an ADGM regulated brokerage whose license covers Shari'a Compliant Regulated Activities, as the FSRA permission names them. New to the terminology? Gharar and Maysir, Sukuk, Zakat and purification are all explained in plain English.

New to the screening method? Read Why a Halal Stock Screener Matters for Halal Investing